Houlihan Lokey (NYSE:HLI) reported quarterly earnings of $1.14 per share which missed the analyst consensus estimate of $1.15 by 0.87 percent. This is a 60.69 percent decrease over earnings of $2.90 per share from the same period last year. The company reported quarterly sales of $456.50 million which missed the analyst consensus estimate of $479.19 million by 4.74 percent. This is a 48.64 percent decrease over sales of $888.80 million the same period last year.
Prelude Therapeutics Q3 EPS $(0.63) Up From $(0.66) YoY
Prelude Therapeutics (NASDAQ:PRLD) reported quarterly losses of $(0.63) per share. This is a 4.55 percent increase over losses of $(0.66) per share from the same period last year.
